Abstract
The blood-brain barrier (BBB) is a unique feature of the human body, preserving brain homeostasis and preventing toxic substances to enter the brain. However, in various neurodegenerative diseases, the function of the BBB is disturbed. Mechanisms of the breakdown of the BBB are incompletely understood and therefore a realistic model of the BBB is essential. We present here the smallest model of the BBB yet, using a microfluidic chip, and the immortalized human brain endothelial cell line hCMEC/D3. Barrier function is modulated both mechanically, by exposure to fluid shear stress, and biochemically, by stimulation with tumor necrosis factor alpha (TNF-α), in one single device. The device has integrated electrodes to analyze barrier tightness by measuring the transendothelial electrical resistance (TEER). We demonstrate that hCMEC/D3 cells could be cultured in the microfluidic device up to 7 days, and that these cultures showed comparable TEER values with the well-established Transwell assay, with an average (± SEM) of 36.9 Ω.cm2 (± 0.9 Ω.cm2) and 28.2 Ω.cm2 (± 1.3 Ω.cm2) respectively. Moreover, hCMEC/D3 cells on chip expressed the tight junction protein Zonula Occludens-1 (ZO-1) at day 4. Furthermore, shear stress positively influenced barrier tightness and increased TEER values with a factor 3, up to 120 Ω.cm2. Subsequent addition of TNF-α decreased the TEER with a factor of 10, down to 12 Ω.cm2. This realistic microfluidic platform of the BBB is very well suited to study barrier function in detail and evaluate drug passage to finally gain more insight into the treatment of neurodegenerative diseases.
Similar content being viewed by others
References
A. Avdeef, Eur. J. Pharm. Sci. 43, 109 (2011)
M. Bellavance, M. Blanchette, D. Fortin, AAPS J. 10, 166 (2008)
R. Booth, H. Kim, Lab Chip 12, 1784 (2012)
F.L. Cardoso, D. Brites, M.A. Brito, Brain Res Rev. 64, 328 (2010)
B.H. Chueh, D. Huh, C.R. Kyrtsos, T. Houssin, N. Futai, S. Takayama, Anal. Chem. 79, 3504 (2007)
L. Cucullo, B. Aumayr, E. Rapp, D. Janigro, Curr. Opin. Drug Discov. Devel. 8, 89 (2005)
L. Cucullo, P. Couraud, B. Weksler, I. Romero, M. Hossain, E. Rapp, D. Janigro, J. Cereb. Blood Flow Metab. 28, 312 (2008)
P.F. Davies, Nat. Clin. Pract. Cardiovasc. Med. 6, 16 (2009)
N.J. Douville, Y. Tung, R. Li, J.D. Wang, M.E.H. El-Sayed, S. Takayama, Anal. Chem. 82, 2505 (2010)
K.A. Frankola, N.H. Greig, W. Luo, D. Tweedie, CNS Neurol. Disord. Drug Targets 10, 391 (2011)
C. Forster, M. Burek, I.A. Romero, B. Weksler, P. Couraud, D. Drenckhahn, J. Physiol. 586, 1937 (2008)
P. Grammas, J. Martinez, B. Miller, Expert Rev. Mol. Med. 13, e19 (2011)
K. Hatherell, P. Couraud, I.A. Romeroc, B. Weksler, G.J. Pilkingtona, J. Neurosci. Methods 199, 223 (2011)
D. Huh, G.A. Hamilton, D.E. Ingber, Trends Cell Biol. 21, 745 (2011)
Y.S. Li, J.H. Haga, S. Chien, J. Biomech. 38, 1949 (2005)
E. Markoutsa, G. Pampalakis, A. Niarakis, I.A. Romero, B. Weksler, P. Couraud, S.G. Antimisiaris, Eur. J. Pharm. Biopharm. 77, 265 (2011)
C. Mc Guire, R. Beyaert, G. van Loo, Trends Neurosci. 34, 619 (2011)
W. Neuhaus, R. Lauer, S. Oelzant, U.P. Fringeli, G.F. Ecker, C.R. Noe, J. Biotechnol. 125, 127 (2006)
E. Neuwelt, N.J. Abbott, L. Abrey, W.A. Banks, B. Blakley, T. Davis, B. Engelhardt, P. Grammas, M. Nedergaard, J. Nutt, W. Pardridge, G.A. Rosenberg, Q. Smith, L.R. Drewes, Lancet Neurol. 7, 84 (2008)
A.M. Palmer, J. Alzheimer Dis. 24, 643 (2011)
R. Paolinelli, M. Coradaa, F. Orsenigoa, E. Dejanaa, Pharmacol. Res. 63, 165 (2011)
K.M. Park, W.J. Bowers, Cell. Signal. 22, 977 (2010)
A. Patabendige, R.A. Skinner, N. J. Abbott. Brain Res. (2012) doi:10.1016/j.brainres.2012.06.057
A.D. van der Meer, A.A. Poot, J. Feijen, I. Vermes, Biomicrofluidics 15, 11103 (2010)
A.D. van der Meer, A. van den Berg, Integr. Biol. (2012) doi: 10.1039/C2IB00176D
J. Wegener, S. Zink, P. Rösen, H.J. Galls, Eur. J. Physiol. 437, 925 (1999)
B.B. Weksler, E.A. Subileau, N. Perrière, P. Charneau, K. Holloway, M. Leveque, H. Tricoire-Leignel, A. Nicotra, S. Bourdoulous, P. Turowski, D.K. Male, F. Roux, J. Greenwood, I.A. Romero, P.O. Couraud, FASEB J. 19, 1872 (2005)
J.H. Yeon, D. Na, K. Choi, S.W. Ryu, C. Choi, J.K. Park, Biomed. Microdev. (2012) doi: 10.1007/s10544-012-9680-5
Acknowledgments
Financial support from NWO - Netherlands Organization for Scientific Research (Nanotox chip, project 11521), and technical assistance of L.J. de Vreede, A.J. Sprenkels, L.I. Segerink, H.L. de Boer and A. Boonstra are gratefully acknowledged. We thank J. Wisniewska-Kruk and I. Klaassen (Ocular Angiogenesis Group at AMC, Amsterdam) for the hCMEC/D3 cell line.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Griep, L.M., Wolbers, F., de Wagenaar, B. et al. BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices 15, 145–150 (2013). https://doi.org/10.1007/s10544-012-9699-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10544-012-9699-7